1. Home
  2. DWSN vs CRDF Comparison

DWSN vs CRDF Comparison

Compare DWSN & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DWSN

Dawson Geophysical Company

HOLD

Current Price

$2.95

Market Cap

113.3M

Sector

Energy

ML Signal

HOLD

Logo Cardiff Oncology Inc.

CRDF

Cardiff Oncology Inc.

HOLD

Current Price

$1.83

Market Cap

130.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DWSN
CRDF
Founded
1952
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
113.3M
130.7M
IPO Year
1995
2012

Fundamental Metrics

Financial Performance
Metric
DWSN
CRDF
Price
$2.95
$1.83
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$9.63
AVG Volume (30 Days)
148.3K
674.1K
Earning Date
03-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
71.11
27.37
EPS
N/A
N/A
Revenue
$145,773,000.00
$365,993.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
49.61
52 Week Low
$1.08
$1.48
52 Week High
$5.54
$4.56

Technical Indicators

Market Signals
Indicator
DWSN
CRDF
Relative Strength Index (RSI) 40.89 45.08
Support Level $1.56 $1.51
Resistance Level $5.54 $2.05
Average True Range (ATR) 0.50 0.12
MACD -0.05 0.01
Stochastic Oscillator 4.61 27.69

Price Performance

Historical Comparison
DWSN
CRDF

About DWSN Dawson Geophysical Company

Dawson Geophysical Co is a provider of onshore seismic data acquisition services with operations throughout the continental United States and Canada. The company acquires and processes 2 D, 3 D, and multi-component seismic data for clients, ranging from oil and gas companies to independent oil and gas operators for use in the onshore drilling and production of oil and natural gas as well as provides multi-client data libraries. It operates through a single segment being Contract seismic data acquisition and processing services. In addition, the company provides multi-component seismic data surveys which involve the recording of alternative seismic waves. Geographically, it generates maximum revenue from the United States.

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company that leverages PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies for various cancers with unmet medical needs. The company focuses on targeting tumor vulnerabilities with treatment combinations of onvansertib, its oral and selective PLK1 inhibitor, and standard-of-care (SoC) therapeutics. The firm's clinical program pipeline focuses on indications such as RAS-mutated metastatic colorectal cancer (mCRC), investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma (mPDAC), small cell lung cancer (SCLC), metastatic triple negative breast cancer (mTNBC), and Chronic Myelomonocytic Leukemia (CMML). Geographically, it operates only in the United States.

Share on Social Networks: